Shanghai Pharmaceuticals Holding Statistics

Total Valuation

Shanghai Pharmaceuticals Holding has a market cap or net worth of HKD 77.74 billion. The enterprise value is 105.84 billion.

Market Cap	77.74B
Enterprise Value	105.84B

Important Dates

The next estimated earnings date is Wednesday, March 26, 2025.

Earnings Date	Mar 26, 2025
Ex-Dividend Date	Sep 17, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.83%
Shares Change (QoQ)	+0.46%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.83B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.56, with an EV/FCF ratio of 29.95.

EV / Earnings	23.74
EV / Sales	0.36
EV / EBITDA	9.56
EV / EBIT	11.71
EV / FCF	29.95

Financial Position

The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.68.

Current Ratio	1.34
Quick Ratio	1.02
Debt / Equity	0.68
Debt / EBITDA	5.46
Debt / FCF	17.63
Interest Coverage	4.65

Financial Efficiency

Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is 3.86%.

Return on Equity (ROE)	6.41%
Return on Assets (ROA)	2.41%
Return on Capital (ROIC)	3.86%
Revenue Per Employee	6.26M
Profits Per Employee	92,572
Employee Count	48,164
Asset Turnover	1.25
Inventory Turnover	6.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.72% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.72%
50-Day Moving Average	12.12
200-Day Moving Average	11.77
Relative Strength Index (RSI)	59.33
Average Volume (20 Days)	4,328,403

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Pharmaceuticals Holding had revenue of HKD 301.73 billion and earned 4.46 billion in profits. Earnings per share was 1.20.

Revenue	301.73B
Gross Profit	33.39B
Operating Income	9.32B
Pretax Income	7.95B
Net Income	4.46B
EBITDA	10.65B
EBIT	9.32B
Earnings Per Share (EPS)	1.20

Full Income Statement

Balance Sheet

The company has 46.95 billion in cash and 62.31 billion in debt, giving a net cash position of -15.36 billion.

Cash & Cash Equivalents	46.95B
Total Debt	62.31B
Net Cash	-15.36B
Net Cash Per Share	n/a
Equity (Book Value)	92.11B
Book Value Per Share	21.19
Working Capital	49.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.33 billion and capital expenditures -2.79 billion, giving a free cash flow of 3.53 billion.

Operating Cash Flow	6.33B
Capital Expenditures	-2.79B
Free Cash Flow	3.53B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 11.07%, with operating and profit margins of 3.09% and 1.48%.

Gross Margin	11.07%
Operating Margin	3.09%
Pretax Margin	2.64%
Profit Margin	1.48%
EBITDA Margin	3.53%
EBIT Margin	3.09%
FCF Margin	1.17%

Dividends & Yields

Shanghai Pharmaceuticals Holding does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-20.45%
Years of Dividend Growth	1
Payout Ratio	85.84%
Buyback Yield	0.83%
Shareholder Yield	0.83%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shanghai Pharmaceuticals Holding has an Altman Z-Score of 2.08. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.08
Piotroski F-Score	n/a